Photodynamic therapy (PDT) is currently under investigation in phase II and III clinical studies for the treatment of tumours in superficial localisations. Thus far, the underlying mechanisms of PDT regarding cellular responses and gene regulation are poorly understood. Photochemically generated singlet oxygen (102) is mainly responsible for cytotoxicity induced by PDT. If targeted cells are not disintegrated, photo-oxidative stress leads to transcription and translation of various stress response and cytokine genes. Tumour necrosis factor (TNF) a, interleukin (IL) 1 and IL-6 are strongly induced by photodynamic treatment, supporting inflammatory action and immunological anti-tumour responses. To investigate the first steps of gene activation, this study focused on the proto-oncogenes c-jun and c-fos, both coding for the transcription factor activator protein 1 (AP-1), which was found to mediate IL-6 gene expression. We here determine the effects of photodynamic treatment on transcriptional regulation and DNA binding of transcription factor AP-1 in order to understand the modulation of subsequent regulatory steps. Photodynamic treatment of epithelial HeLa cells was performed by incubation with Photofrin and illumination with 630 nm laser light in vitro. Expression of the c-jun and c-fos genes was determined by way of Northern blot analysis, and DNA-binding activity of the transcription factor AP-1 was evaluated by electrophoretic mobility shift assay (EMSA). Photofrin-mediated photosensitisation of HeLa cells resulted in a rapid and dose-dependent induction of both genes but preferential expression of c-jun. Compared with the transient expression of c-jun and c-fos by phorbol ester stimulation, photodynamic treatment led to a prolonged activation pattern of both immediate early genes. Furthermore, mRNA stability studies revealed an increased half-life of c-jun and c-fos transcripts resulting from photosensitisation. Although mRNA accumulation after PDT was stronger and more prolonged compared with phorbol ester stimulation, with regard to AP-1 DNA-binding activity, phorbol ester was more efficient. Surprisingly, in addition to the activation of AP-1 DNA-binding via PDT, photodynamic treatment can decrease AP-1 DNA-binding of other strong inducers, such as the protein kinase C-mediated pathway of phorbol esters and the antioxidant pyrrolidine dithiocarbamate (PDTC). This study demonstrates a strong induction of c-jun and c-fos expression by PDT, with prolonged kinetics and mRNA stabilisation as compared with activation by phorbol esters. Interestingly, this observation is not coincident with an overinduction of AP-1 DNA-binding, hence suggesting that post-translational modifications are dominant regulatory mechanisms after PDT that tightly control AP-1 activity in the nucleus thus limiting the risk of deregulated oncogene expression.
Photodynamic therapy (PDT) is a novel therapeutic approach consisting of topical or systemic application of a photosensitising agent and activation by subsequent illumination with tissue-penetrating visible light. The combination of drug uptake in malignant tissue and selective light delivery provides an effective tumour therapy with efficient cytotoxicity and minimal damage to normal tissue (Pass, 1993) .
Oxidative stress caused by singlet oxygen ('02) iS responsible for the effects induced by PDT (Weishaupt et al., 1976) . Photosensitisation activates expression of a variety of stress-response genes coding for heat shock proteins, glucose-regulated proteins and haem oxygenase Ryter et al., 1991) . The exact functions of these stress proteins are still unclear; however, they might participate in a protective reaction to oxidative stress. Evans et al. (1990) demonstrated the dose-dependent production of murine tumour necrosis factor (TNF) in supernatants obtained from PDT-treated macrophages in vitro. Furthermore, interleukin (IL) 6 (Kick et al., 1995) and IL-la/: (G Kick et al., manuscript submitted) protein synthesis induced by PDT in epithelial cell lines was recently discovered. These cytokines have the ability to up-regulate anti-tumour responses and may be good candidates to mediate the local inflammatory reaction. In studying molecular mechanisms of PDT-induced IL-6 expression at the level of gene regulation, electrophoretic mobility shift assays (EMSAs) revealed increased AP-1 DNA-binding activity at the distal AP-1 element of the IL-6 promoter (Kick et al., 1995) .
To elucidate further the underlying regulation, the present study analysed the effect of PDT on the AP-1 transcription factor genes c-jun and c-fos, which are known as protooncogenes. Both genes are members of a multigene family coding for transcription factors (Curran and Franza, 1988; Ryder et al., 1989) . By interaction of their leucine zipper domain, Jun and Fos proteins form dimeric complexes (Sassone-Corsi et Landschulz et al., 1988; Kouzarides and Ziff, 1988; Gentz et al., 1989) . This mode of dimerisation is a characteristic feature of the bZIP family, which includes Jun-, Fos-, activating transcription factor (ATF), cAMP-responsive element-binding (CREB) proteins and others that can bind to the AP-1 DNA motifs and Induction of c-jun and c-fos by photodynamic therapy G Kick et a! factor in response to singlet oxygen was a further reason for the present investigation, as in vitro photosensitisation by Photofrin is a system that generates this reactive oxygen intermediate (Gollnick, 1968; Weishaupt et al., 1976) .
Moreover, proto-oncogene expression could be a relevant aspect of cancer therapy. Recent studies describe c-jun and c-fos expression as associated with programmed cell death (Smeyne et al., 1993; Manome et al., 1993; Kim and Beck, 1994) , multidrug-resistant phenotype (Scanlon et al., 1994) , and deregulated expression has been discussed as a prerequisite of their transforming potential (Miller et al., 1984; Bos et al., 1990; Lee et al., 1988; van den Berg et al., 1993 (Hartmann Analytic, Braunschweig, Germany) by random hexamer priming (Feinberg and Vogelstein, 1983 [100 mM Tris-HCl, pH 7.5, 500 mM sodium chloride, 10 mM EDTA, 50% (v/v) glycerol, 2 mM DTT, 2 pl 1% (v/v) Nonidet P 40] (Sigma), and approximately 10 000 c.p.m. of a y-32P-labelled dsDNA probe with a specific activity not less than 3000 Ci mmol-'. After 30 min at room temperature, the samples were loaded on a 4% non-denaturing polyacrylamide gel in 0.5 x Tris -borate-EDTA buffer. Electrophoresis was performed in a vertical EMSA system (AGS, Heidelberg, Germany) at 15 V cm-' for 1.5 h. Gels were dried at 80°C for 30 min and then exposed for autoradiography.
Results
Our previous study identified the DNA binding of transcription factor AP-1 as an important regulatory event Inducdon of c-jun and c-fos by photodynamic therapy G Kick et al of PDT-induced IL-6 gene expression (Kick et al., 1995 Since photodynamic action is caused by oxidative stress, we were prompted to explore the influence of antioxidants on PDT-mediated mRNA uptake. Particularly pyrrolidine dithiocarbamate (PDTC) and N-acetyl-L-cysteine (NAC) were tested in multiple studies for efficient radical scavenging at non-cytotoxic concentrations (Schreck et al., 1992; Aruoma et al., 1989; Burgunder et al., 1989) . In our in vitro system, PDTC (100,M) led to induction of c-jun and c-fos mRNA expression ( Figure 3 , lane 2). This finding concurs with a previous study that found AP-1 active under both oxidant and antioxidant conditions (Meyer et al., 1993) . After exposure to NAC (30 mM), only very weak signals were detectable ( Figure 3 , lane 3), but both antioxidants preferentially induced c-fos transcripts. Interestingly, c-jun mRNA induction upon PDT was reduced by PDTC and NAC, and for the latter c-jun was selectively suppressed (lanes 5 to 7). Thus, it appeared that c-jun expression is mainly caused by the oxidative potential of PDT and could be regarded as an oxidative stress-responsive member of the AP-1 transcription factor family. However, c-fos appeared to be much more strongly activated at the mRNA level under antioxidant conditions.
In order to analyse if the strong and prolonged expression of c-jun and c-fos mRNA by PDT is paralleled by an increased AP-1 DNA-binding activity, protein extracts were prepared at various points in time after photodynamic treatment. Again, TPA stimulation was used as a control. Nuclear extracts were incubated with a 32P-labelled dsDNA oligonucleotide encompassing the AP-1 consensus sequence. For a comparison at the level of AP-l-binding activity, mobility shift assays were carried out with equal amounts of extracted proteins. An increased AP-1 DNA-binding activity could be detected as early as 15 min following PDT or phorbol ester stimulation (data not shown), and strongest activity was observed after 4 h (Figure 4 The antioxidant PDTC was shown to activate transcription factor AP-1 at the transcriptional and post-translational level (Meyer et al., 1993) . Accordingly, we detected an increased AP-1 DNA-binding activity following antioxidant treatment (Figure 4, lane 6) . Interestingly, the strong AP-1 activity upon PDTC addition was markedly reduced if antioxidant treatment was combined with photodynamic treatment (Figure 4 , lanes 6 and 7) at conditions that otherwise independently led to AP-1 activation (lane 2).
The DNA-binding activity induced by TPA was also reduced if phorbol ester stimulation was combined with photodynamic treatment. The addition of TPA 15 min after 
Discussion
In this study, photodynamic treatment of human epithelial HeLa cells led to rapid and strong induction of c-jun and cfos mRNA expression. Both genes were induced by similar kinetics, but c-jun was much more responsive to PDT. Striking differences were apparent when kinetics of c-jun and c-fos gene induction by PDT (Luna et al.., 1994; Treisman, 1986 (Shyu et al., 1989; Chen and Shyu. 1994) . The second domain is positioned in the transcribed sequence and referred to as the coding region determinant of mRNA instability of the c-fos gene (Kabnick and Housman, 1988; Chen et al., 1992) . At the same time, AT-rich sequences of the untranslated region of c-jun may be involved in the post-transcriptional regulation of the c-jun gene (Hattori et al., 1988) . Oxidative stress resulting from photosensitisation might interfere with protein behaviour at the described destabilising sites. with unspecific mRNA-degrading activities or transcriptional elongation blocks (Plet et al., 1995 Lee et al.. 1988; Meijlink et al.. 1985; Rahmsdorf et al., 1987) . Tumour induction by high-level c-fos expression has been observed in an animal model; c-fos transgenic mice were constructed under the control of the metallothionein promoter and the FBJ 3' LTR, which was necessary to stabilise the exogenous fos mRNA (Ruither et al., 1989) .
Furthermore, it appears insufficient to evaluate the risk of carcinogenesis by AP-I at the level of mRNA expression, since there are several post-translational regulatory mechanisms and, moreover, synergistic or antagonistic interactions between AP-1 family members and possibly other transcription factors.
In the case of photodynamic treatment, post-translational regulation also appears to be a powerful mechanism in controlling AP-1 activity. Although mRNA accumulation by PDT was stronger and even prolonged in comparison with phorbol ester stimulation, on the level of protein DNAbinding, photodynamic treatment was much less efficient. Apparently, the binding capacity of AP-1 is determined by regulatory mechanisms other than transcriptional activation of the nuclear factor genes. According to previous reports, AP-1 was shown to be induced under both pro-oxidant and anti-oxidant conditions (Abate et al., 1990; Xanthoudakis et al., 1992) . Stronger DNA-binding was caused by the antioxidant state (Meyer et al.. 1993; Schenk et al., 1994; Li and Jaiswal, 1994) . Superoxide anions and hydrogen peroxide were found to be weak inducers of AP-1 binding (Amstad et al., 1992; Devary et al., 1991) . Reversible oxidation of a single, conserved cysteine residue located in the DNA-binding domain of AP-1 proteins modulates their DNA-binding activity (Abate et al., 1990) . Oxidation of these cysteine sites inhibits the DNA-binding activity of AP-1 (Abate et al., 1990; Bannister et al., 1991; Frame et al., 1991) . Ref-I (redox factor 1), a DNA repair protein, was found to reactivate in vitro oxidised AP-1 by reducing this cysteine residue (Xanthoudakis et al., 1992) . Singlet oxygen-mediated redox regulation of AP-1 binding could therefore explain the discrepancy between strong mRNA induction and weak DNA-binding of AP-1 after PDT. Furthermore, oxidation of cysteine residues might be responsible for the downregulation of AP-1 DNA-binding induced by the antioxidant PDTC upon concomitant photodynamic treatment.
As phorbol ester-mediated AP-1 DNA activation is caused by dephosphorylation (Boyle et al., 1991; Papavassiliou et al., 1992) and PKC seems not to be involved in PDT-mediated regulation of AP-1 in HeLa cells (Kick et al., 1995) , redox regulation might be regarded as the dominant pathway of AP-1 DNA-binding modulated upon PDT. This argument is strengthened by the fact that activation of AP-1 upon TPA was suppressed by PDT both before and after the addition of the phorbol ester. However, there is growing evidence for AP-1 regulating cytokine gene expression in response to PDT. This research has identified Photofrin-mediated photosensitisation as a potent inducer of c-jun and c-fos mRNA expression but a comparatively weak activator of AP-1 DNA-binding. Mechanisms of PDT-mediated AP-1 regulation differ from mechanisms of activation by other reactive oxygen intermediates and phorbol esters, thus suggesting a unique regulatory pathway. It seems unlikely that deregulated mRNA expression could enhance the potential risk of PDTinduced carcinogenesis, since AP-1 DNA-binding is tightly controlled.
